Cited by 101Cancer-related Molecular PathwaysLiver physiology and pathologyHippo pathway signaling and YAP/TAZ

Liver-Specific pRB Loss Results in Ectopic Cell Cycle Entry and Aberrant Ploidy

Open access
Mayhew, Christopher N., Bosco, Emily E., Fox, Sejal R., Okaya, Tomohisa, Tarapore, Pheruza, Schwemberger, Sandy J., Babcock, George F., Lentsch, Alex B. +2 more·2005·Cancer Research

Abstract

The liver exhibits an exquisitely controlled cell cycle, wherein hepatocytes are maintained in quiescence until stimulated to proliferate. The retinoblastoma tumor suppressor, pRB, plays a central role in proliferative control by inhibiting inappropriate cell cycle entry. In many cases, liver cancer arises due to aberrant cycles of proliferation, and correspondingly, pRB is functionally inactivated in the majority of hepatocellular carcinomas. Therefore, to determine how pRB loss may provide conditions permissive for deregulated hepatocyte proliferation, we investigated the consequence of somatic pRB inactivation in murine liver. We show that liver-specific pRB loss results in E2F target gene deregulation and elevated cell cycle progression during post-natal growth. However, in adult livers, E2F targets are repressed and hepatocytes become quiescent independent of pRB, suggesting that other factors may compensate for pRB loss. Therefore, to probe the consequences of acute pRB inactivation in livers of adult mice, we gave adenoviral-Cre by i.v. injection. We show that acute pRB loss is sufficient to elicit E2F target gene expression and cell cycle entry in adult liver, demonstrating a critical role for pRB in maintaining hepatocyte quiescence. Finally, we show that liver-specific pRB loss results in the development of nuclear pleomorphism associated with elevated ploidy that is evident in adult mice harboring both acute and chronic pRB loss. Together, these results show the crucial role played by pRB in maintaining hepatocyte quiescence and ploidy in adult liver in vivo and underscore the critical importance of delineating the consequences of acute pRB loss in adult animals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-4221

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 68 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Michalopoulos GK, DeFrances MC. Liver regenera- tion. Science 1997;276:60-6.
  2. Coleman WB. Mechanisms of human hepatocarci- nogenesis. Curr Mol Med 2003;3:573-88.
  3. Postic C, Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000;26:149-50.

Cited by

Sorted by citations

Authors
Mayhew, C. N., Bosco, E. E., Fox, S. R., Okaya, T., Tarapore, P., Schwemberger, S. J., Babcock, G. F., Lentsch, A. B., Fukasawa, K., & Knudsen, E. S.
Affiliations
  • 1Cell Biology and Departments of
  • 2Surgery, College of Medicine and
  • University of Cincinnati (US)
Venue
Cancer Research
Published
2005-06-01
Volume
65
Issue
11
Pages
4568-4577
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2107840687
Cited by
101
References
68
Citations by year
2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 3 · 2012: 7
FWCI
4.04
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Hennepin County Medical Center
  • National Cancer Institute (CA-106471, T32-CA59268, R01CA106471, T32CA059268)
  • National Institute of Environmental Health Sciences (E30-ES 06096)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
Keywords
retinoblastoma protein, hepatocyte quiescence, cell cycle entry, E2F target genes, hepatocyte proliferation, nuclear pleomorphism, polyploidy, hepatocellular carcinoma, liver cancer
MeSH terms
Animals, Cell Cycle, DNA-Binding Proteins, Liver, Ploidies, Transcription Factors, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Cell Cycle Proteins, Gene Silencing, Hepatocytes, Cell Growth Processes, E2F Transcription Factors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review